Diagnostic Imaging Staff

Articles by Diagnostic Imaging Staff

University of Pennsylvania researchers have developed an experimental MRI contrast agent capable of targeting tumors, according to a report in the journal ACS Nano. Its coating, instead of targeting particular cancer receptors - which can be hit-or-miss and depend on the cancer - is attracted to the acidic environments in which tumors generally thrive.